Metraipolis › archive › dc_e5d9f243ca76

Oxaliplatin versus irinotecan as first-line therapy in metastatic colorectal cancer with prior adjuvant treatment: a retrospective study on efficacy,… — Europe PMC PMID:41333219

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41333219
DOI
10.3389/fonc.2025.1631022
License (as archived)
solo-consultazione
Archived
2026-11-08T12:31:23.556Z
SHA-256 of the archived text
ac240c3a80ac86f4cca27fefc0e6618a7c6d47b6964cdbfac2b555fe1074f50d
Stable URL of this page
https://metraipolis.com/documento/dc_e5d9f243ca76

How to cite

Oxaliplatin versus irinotecan as first-line therapy in metastatic colorectal cancer with prior adjuvant treatment: a retrospective study on efficacy,… — Europe PMC PMID:41333219 — Europe PMC (en), https://europepmc.org/article/MED/41333219 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5d9f243ca76 (Metraipolis archive dc_e5d9f243ca76, sha256 ac240c3a80ac86f4cca27fefc0e6618a7c6d47b6964cdbfac2b555fe1074f50d)
BibTeX
@misc{dce5d9f243ca76,
  title = {Oxaliplatin versus irinotecan as first-line therapy in metastatic colorectal cancer with prior adjuvant treatment: a retrospective study on efficacy,… — Europe PMC PMID:41333219},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41333219},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5d9f243ca76; sha256 ac240c3a80ac86f4cca27fefc0e6618a7c6d47b6964cdbfac2b555fe1074f50d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333219. Agents can read the archived copy with the MCP tool read_document.